Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 372

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs

Lim, Stephen S, Gaziano, Thomas A, Gakidou, Emmanuela, Reddy, K Srinath, Farzadfar, Farshad, Lozano, Rafael, Rodgers, Anthony·2007·The Lancet
DOI 10.1016/s0140-6736(07)61699-7
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61699-7

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 46

  1. Strong, 2005, Preventing chronic diseases: how many lives can we save?, Lancet, 366, 1578, 10.1016/S0140-6736(05)67341-2 · DOI · Paper page
  2. Omran, 1971, The epidemiologic transition: a theory of the epidemiology of population change, Milbank Memorial Fund Quarterly, 49, 509, 10.2307/3349375 · DOI · Paper page
  3. Ezzati, 2005, Rethinking the “Diseases of Affluence” paradigm: global patterns of nutritional risks in relation to economic development, PLoS Med, 2, e133, 10.1371/journal.pmed.0020133 · DOI · Paper page
  4. Murray, 2003, Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk, Lancet, 361, 717, 10.1016/S0140-6736(03)12655-4 · DOI · Paper page
  5. Shibuya, 2003, WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty, BMJ, 327, 154, 10.1136/bmj.327.7407.154 · DOI · Paper page
  6. Gaziano, 2006, Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis, Lancet, 368, 679, 10.1016/S0140-6736(06)69252-0 · DOI · Paper page
  7. Gaziano, 2007, Scaling up interventions for chronic disease prevention: the evidence, Lancet, 10.1016/S0140-6736(07)61697-3 · DOI · Paper page
  8. Asaria, 2007, Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use, Lancet, 10.1016/S0140-6736(07)61698-5 · DOI · Paper page
  9. 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 · DOI · Paper page
  10. Mendis, 2005, WHO Study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE), Bull World Health Organ, 83, 820
  11. Jackson, 2005, Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk, Lancet, 365, 434, 10.1016/S0140-6736(05)17833-7 · DOI · Paper page
  12. Murray, 2003, Effectiveness and costs of interventions to lower blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular disease risk, Lancet, 361, 717, 10.1016/S0140-6736(03)12655-4 · DOI · Paper page
  13. Wald, 2003, A strategy to reduce cardiovascular disease by more than 80%, BMJ, 326, 1419, 10.1136/bmj.326.7404.1419 · DOI · Paper page
  14. Yusuf, 2002, Two decades of progress in preventing vascular disease, Lancet, 360, 2, 10.1016/S0140-6736(02)09358-3 · DOI · Paper page
  15. Reddy, 2007, The preventive polypill—much promise, insufficient evidence, N Engl J Med, 356, 212, 10.1056/NEJMp068219 · doi:10.1056/nejmp068219
  16. Johns, 2007, Estimated global resources needed to attain universal coverage of maternal and newborn health services, Bull World Health Organ, 85, 256, 10.2471/BLT.06.032037 · DOI
  17. Stenberg, 2007, A financial road map to scaling up essential child health interventions in 75 countries, Bull World Health Organ, 85, 305, 10.2471/BLT.06.032052 · DOI
  18. Williams, 2006, Evolution of hypertensive disease: a revolution in guidelines, Lancet, 368, 6, 10.1016/S0140-6736(06)68943-5 · DOI
  19. Lawes, 2004, Chapter 6: High blood pressure
  20. Lawes, 2004, Chapter 7: High cholesterol
  21. Ezzati, 2004, Chapter 11: Smoking and oral tobacco use, 883
  22. Huxley, 2006, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies, BMJ, 332, 73, 10.1136/bmj.38678.389583.7C · DOI · Paper page
  23. 2003, The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region, Diabetes Care, 26, 360, 10.2337/diacare.26.2.360 · DOI · Paper page
  24. Bronnum-Hansen, 2001, Survival and cause of death after myocardial infarction: the Danish MONICA study, J Clin Epidemiol, 54, 1244, 10.1016/S0895-4356(01)00405-X · DOI
  25. Bronnum-Hansen, 2001, Long-term survival and causes of death after stroke, Stroke, 32, 2131, 10.1161/hs0901.094253 · DOI · Paper page
  26. Anderson, 1991, Cardiovascular disease risk profiles, Am Heart J, 121, 293, 10.1016/0002-8703(91)90861-B · DOI · Paper page
  27. Ranson, 2003, Constraints to expanding access to health interventions: an empirical analysis and country typology, J Int Development, 15, 15, 10.1002/jid.964 · DOI
  28. Yusuf, 1998, Overview of results of randomized clinical trials in heart disease I. Treatments following myocardial infarction, JAMA, 260, 2088, 10.1001/jama.1988.03410140100032 · DOI · Paper page
  29. Evans, 2005, Methods to assess the costs and health effects of interventions for improving health in developing countries, BMJ, 331, 1137, 10.1136/bmj.331.7525.1137 · DOI
  30. Jackevicius, 2002, Adherence with statin therapy in elderly patients with and without acute coronary syndromes, JAMA, 288, 462, 10.1001/jama.288.4.462 · DOI · Paper page
  31. Ellis, 2004, Suboptimal statin adherence and discontinuation in primary and secondary prevention populations: should we target patients with the most to gain?, J Gen Inter Med, 19, 638, 10.1111/j.1525-1497.2004.30516.x · DOI · Paper page
  32. Kopjar, 2003, Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population, Am J Cardiol, 92, 1106, 10.1016/j.amjcard.2003.07.008 · DOI
  33. Benner, 2002, Long-term persistence in use of statin therapy in elderly patients, JAMA, 288, 455, 10.1001/jama.288.4.455 · DOI · Paper page
  34. Gislason, 2006, Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction, Eur Heart J, 27, 1153, 10.1093/eurheartj/ehi705 · DOI · Paper page
  35. Newby, 2006, Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease, Circulation, 113, 203, 10.1161/CIRCULATIONAHA.105.505636 · DOI · Paper page
  36. Mantel-Teeuwisse, 2004, Long term persistence with statin treatment in daily medical practice, Heart, 90, 1065, 10.1136/hrt.2003.026187 · DOI
  37. Bovet, 2002, Monitoring one-year compliance to antihypertension medication in the Seychelles, Bull World Health Organ, 80, 33
  38. Gutierrez, 2004, Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?, Lancet, 364, 63, 10.1016/S0140-6736(04)16590-2 · DOI
  39. Bryce, 2005, Can the world afford to save the lives of 6 million children each year?, Lancet, 365, 2193, 10.1016/S0140-6736(05)66777-3 · DOI
  40. Martines, 2005, Neonatal survival: a call for action, Lancet, 365, 1189, 10.1016/S0140-6736(05)71882-1 · DOI · Paper page
  41. Mendis, 2007, The availability and affordability of selected essential medicines for chronic disease in six low- and middle-income countries, Bull World Health Organ, 58, 279, 10.2471/BLT.06.033647 · DOI · Paper page
  42. Abegunde, 2007, Can non-physician health-care workers assess and manage cardiovascular risk in primary care?, BullWorld Health Organ, 85, 432, 10.2471/BLT.06.032177 · DOI
  43. Schedlbauer, 2004, Interventions to improve adherence to lipid lowering medication, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD004371.pub2 · DOI
  44. Schroeder, 2004, Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD004804 · DOI · Paper page
  45. Victora, 2004, Achieving universal coverage with health interventions, Lancet, 364, 1541, 10.1016/S0140-6736(04)17279-6 · DOI · Paper page
  46. Egger, 2005, Antiretroviral therapy in resource poor settings: scaling up inequalities, Int J Epidemiol, 34, 509, 10.1093/ije/dyi110 · DOI

Cited by

See all 372

Metadata

Authors
Lim, S. S., Gaziano, T. A., Gakidou, E., Reddy, K. S., Farzadfar, F., Lozano, R., & Rodgers, A.
Venue
The Lancet
Publisher
Elsevier BV
Published
2007-12
Volume
370
Issue
9604
Pages
2054-2062
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(07)61699-7
OpenAlex
W2103109120
Cited by
372
References
6
FWCI
22.73
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. https://app.cochat.ai/papers/10.1016/s0140-6736(07)61699-7
The paper
Lim, S. S., Gaziano, T. A., Gakidou, E., Reddy, K. S., Farzadfar, F., Lozano, R., & Rodgers, A. (2007). Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. The Lancet. https://doi.org/10.1016/s0140-6736(07)61699-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.